Search Within

Sujata Patil

  1. "Biostatistics Service"
Formats
  1. Meeting Abstract (278)
  2. Journal Article (230)
  3. Correspondence (1)
  4. Research Letter (1)
  5. Review (1)
Groups
  1. Biostatistics Service (511)
  2. Epidemiology and Biostatistics (511)
  3. Department of Medicine (363)
  4. Solid Tumor Oncology Division (358)
  5. Survivorship Research (323)
  6. Surgery (247)

More Groups

People
  1. Clifford Hudis (141)
  2. Larry Norton (97)
  3. Robert Motzer (93)
  4. Monica Morrow (83)
  5. Darren Feldman (81)
  6. Edi Brogi (65)

More People

Years
  1. 2024 (3)
  2. 2023 (3)
  3. 2022 (10)
  4. 2021 (24)
  5. 2020 (29)
  6. 2019 (31)

More Years

Publications
  1. Journal of Clinical Oncology (170)
  2. Annals of Surgical Oncology (67)
  3. Cancer Research (55)
  4. Cancer (23)
  5. Breast Cancer Research and Treatment (18)
  6. Clinical Cancer Research (14)

More Publications

Publishers
  1. American Society of Clinical Oncology (172)
  2. Springer (92)
  3. American Association for Cancer Research (71)
  4. Elsevier Inc. (34)
  5. Wiley Blackwell (33)
  6. Oxford University Press (19)

More Publishers

Results (511)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase I study of PI3Kα inhibitor BYL719 + aromatase inhibitor (AI) in patients (pts) with hormone receptor-positive (HR+) metastatic breast cancer (MBC)
    Meeting Abstract

    Shah, P. D.; Moynahan, M. E.; Modi, S.; Hamilton, N.; Caravella, B. A.; Zamora, S.; Dang, C.; Gilewski, T.; Traina, T.; Comen, E.; more...
    Cancer Research (2015)

    Fulltext@MSK | Save
  • Lobular carcinoma in situ: A 29-year longitudinal experience evaluating clinicopathologic features and breast cancer risk
    Journal Article

    King, T. A.; Pilewskie, M.; Muhsen, S.; Patil, S.; Mautner, S. K.; Park, A.; Oskar, S.; Guerini Rocco, E.; Boafo, C.; Gooch, J. C.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Oncotype DX in bilateral synchronous primary invasive breast cancer
    Meeting Abstract

    Gunthner-Biller, M.; Stempel, M.; Patil, S.; King, T.
    Annals of Surgical Oncology (2015)

    Fulltext@MSK | Save
  • Metaplastic breast cancer is resistant to standard breast cancer treatment modalities
    Meeting Abstract

    Mautner, S. K.; Giri, D.; Stempel, M.; Patil, S.; Eaton, A.; Van Zee, K. J.; King, T.; Morrow, M.; Plitas, G.
    Annals of Surgical Oncology (2015)

    Fulltext@MSK | Save
  • Is preoperative axillary imaging beneficial in identifying clinically node-negative patients requiring axillary lymph node dissection?
    Meeting Abstract

    Pilewskie, M.; Jochelson, M.; Gooch, J.; Patil, S.; Stempel, M.; Morrow, M.
    Annals of Surgical Oncology (2015)

    Fulltext@MSK | Save
  • Do close or positive mastectomy margins mandate the use of radiotherapy?
    Meeting Abstract

    Anderson, D. N.; Sakr, R.; Patil, S.; Stempel, M.; Morrow, M.
    Annals of Surgical Oncology (2015)

    Fulltext@MSK | Save
  • The relationship between year of treatment and local recurrence (LR) of ductal carcinoma in situ (DCIS): Analysis of 3,000 women treated with breast-conserving surgery over 30 years
    Meeting Abstract

    Subhedar, P.; Olcese, C.; Patil, S.; Morrow, M.; Van Zee, K. J.
    Annals of Surgical Oncology (2015)

    Fulltext@MSK | Save
  • Development of a risk stratification system to guide treatment for female germ cell tumors
    Journal Article

    Meisel, J. L.; Woo, K. M.; Sudarsan, N.; Eng, J.; Patil, S.; Jacobsen, E. P.; Murali, R.; Gardner, G. J.; Bosl, G. J.; Aghajanian, C.; more...
    Gynecologic Oncology (2015)

    Fulltext@MSK | Save
  • Phase I/II trial of paclitaxel with ifosfamide followed by high-dose paclitaxel, ifosfamide, and carboplatin (TI-TIC) with autologous stem cell reinfusion for salvage treatment of germ cell tumors
    Journal Article

    Feldman, D. R.; Glezerman, I.; Patil, S.; Van Alstine, L.; Bajorin, D. F.; Fischer, P.; Hughes, A.; Sheinfeld, J.; Bains, M.; Reich, L.; more...
    Clinical Genitourinary Cancer (2015)

    Fulltext@MSK | Save
  • TBCRC 019: A phase II trial of nanoparticle albumin-bound paclitaxel with or without the anti-death receptor 5 monoclonal antibody tigatuzumab in patients with triple-negative breast cancer
    Journal Article

    Forero-Torres, A.; Varley, K. E.; Abramson, V. G.; Li, Y.; Vaklavas, C.; Lin, N. U.; Liu, M. C.; Rugo, H. S.; Nanda, R.; Storniolo, A. M.; more...
    Clinical Cancer Research (2015)

    Fulltext@MSK | Save